Report cover image

Clinical Trials: Psychedelic Therapeutics

Publisher GlobalData
Published Jul 30, 2024
Length 32 Pages
SKU # GBDT19177586

Description

Clinical Trials: Psychedelic Therapeutics


Summary

This report provides a review of global psychedelic therapeutic clinical trials derived from the GlobalData’s Clinical Trials Database. The aim of this report is to identify key analyses and segmentations of these trials.

As the number of psychedelic therapeutic clinical trials continues to increase, a deeper understanding of these trials, such as sponsor type, location, and phase, are reviewed.

Scope
  • Non-industry sponsors outnumber industry sponsors for psychedelic therapy trials. They account for 58% of psychedelic therapy trials, with the largest margin of difference seen in 2021.
  • Yale University is the leading non-industry sponsor while Johnson & Johnson is the leading industry sponsor.
  • Central nervous system is by far the top therapy area for psychedelic therapy trials, tested in 92% of all psychedelic therapy trials. The top indication is depression.
  • At the country level, the US leads with 88% of all North American studies, followed by China.
  • Phase II trials of psychedelic therapies have outnumbered all other phases since 2013.
Reasons to Buy
  • Identifies and analyzes psychedelic therapeutic clinical trials by multiple trial designs, such as trial start year, geographic distribution, phase and drug details.
  • Examines the cause of the increase of psychedelic clinical trials.
  • Gives reasons for certain trends seen in psychedelic trials.
  • Breaks down trials by sponsor type and top sponsors.
  • Looks at the virtual components used for psychedelic trials.
  • Describes the leading drugs used in psychdelic trials.

Table of Contents

32 Pages
1 Table and Figures
2 Executive Summary
3 Introduction
Report Scope
Methodology
4 Psychedelic Therapeutic Trials
Number of psychedelic therapy trials, by status (2003-24)
Psychedelic therapy trials, by regional distribution (2013-24)
Number of Psychedelic therapy trials, by top five countries (2018-24)
Number of Psychedelic therapy trials, by top five US States
Psychedelic therapy clinical trials, by year and phase (2013-24)
Psychedelic clinical trials, by sponsor type (2004-24)
Psychedelic clinical trials, by top 10 non-industry sponsors
Psychedelic clinical trials, by top 10 industry sponsors
Terminated/suspended/withdrawn psychedelic therapy clinical trials, by leading sponsors
Terminated/suspended/withdrawn psychedelic therapy clinical trials, by leading reason
Number of psychedelic clinical trials, by virtual component and type of mobile healthcare
Single-country and multinational psychedelic therapy trials, by region
Top 10 indications in psychedelic therapy clinical trials, by phase
Top 10 psychedelic therapies, by clinical trial count
Top five psychedelic drugs with highest drug-specific likelihood of approval
6 Key Findings
7 Appendix
About the Authors
About GlobalData
Contact Us
List of Tables
Table 1: Top 10 psychedelic therapies, by clinical trial count
Table 2: Top five psychedelic drugs with highest drug-specific likelihood of approval
List of Figures
Figure 1: Number of psychedelic therapy trials, by status (2003-24)
Figure 2: Psychedelic therapy trials, by regional distribution (2013-24)
Figure 3: Number of Psychedelic therapy trials, by top five countries (2018-24)
Figure 4: Number of Psychedelic therapy trials, by top five US States
Figure 5: Psychedelic therapy clinical trials, by year and phase (2013-24)
Figure 6: Psychedelic clinical trials, by sponsor type (2004-24)
Figure 7: Psychedelic clinical trials, by top 10 non-industry sponsors
Figure 8: Psychedelic clinical trials, by top 10 industry sponsors
Figure 9: Terminated/suspended/withdrawn psychedelic therapy clinical trials, by leading sponsors
Figure 10: Terminated/suspended/withdrawn psychedelic therapy clinical trials, by leading reason
Figures 11 and 12: Number of psychedelic clinical trials, by virtual component and type of mobile healthcare
Figure 13: Single-country and multinational psychedelic therapy trials, by region
Figure 14: Top 10 indications in psychedelic therapy clinical trials, by phase
Figure 15: Top 10 psychedelic therapies, by clinical trial count

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us